Strategic treatment pause of first-line immune checkpoint inhibitor + VEGFR-tyrosine kinase inhibitor in patients with good or intermediate risk metastatic renal cell carcinoma (mRCC) in response at 1 year of treatment (SPICI-GETUG R05): A...
| Autor: | Gross-Goupil, Marine, Lefort, Felix, Larroquette, Mathieu, Asselineau, Julien, Frison, Eric, Albiges, Laurence, Ravaud, Alain |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS487-TPS487, 140p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|